Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Complian...(d holds a Bachelor of Arts from Georgeto...),Health
Navigation Links
Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
Date:11/1/2007
d holds a Bachelor of Arts from Georgetown University.
Cephalon, Inc.
Cephalon, Inc. is an international biopharmaceutical company, recently inducted into the World Economic Forum Community of Global Growth Companies. For 20 years, the company has been dedicated to the discovery, development and commercialization of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction. A member of the Fortune 1000, Cephalon currently employs approximately 3,000 people in the United States and Europe. U.S. sites include the company's headquarters in Frazer, Pennsylvania, and offices, laboratories or manufacturing facilities in West Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis, Minnesota. Cephalon's European headquarters are located in Maisons-Alfort, France.
The company's proprietary products in the United States include: AMRIX(TM) (cyclobenzaprine hydrochloride extended-release capsules), PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA(R) (fentanyl buccal tablet) [C-II], TRISENOX(R) (arsenic trioxide) injection, VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. Full prescribing information on its U.S. products is available at http://www.cephalon.com or by calling 1-800-896-5855.
In addition to historical facts or statements of current condition,
this press release may contain forward-looking statements. Forward-looking
statements provide Cephalon's current expectations or forecasts of future
events. These may include statements regarding anticipated scientific
progress on its research programs, development of potential pharmaceutical
products, interpretation of clinical results, prospects for regulatory
approval, manufa
'/>"/>
| SOURCE Cephalon, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Provigil Patent Extension Accorded To Cephalon
2. Where Burnt Out Executives De-stress in Natures Lap
3. Asian Business Executives Urged to Be Eco-friendly
4. BMA Welcomes Scottish Executives Move to Raise the Purchase Age of Cigarettes
5. Clintons new problem - Is the outgoing American president suffering from skin cancer?
6. Past President Narayanans Condition Still Critical
7. President and Founder of National Obesity Forum Resigns
8. President Bush Urges Citizens to Invest In Health Savings Account (HSAs)
9. President Bush proposes HSAs scheme for the benefit of both the workers and the country
10. President’s verdict: no need to panic over bird fl
11. Delhi Hospitals On Standby For President Bush
Post Your Comments:
(Date:12/4/2009)...ican Association of Homes and Services for the Agi...the Community Living and Supportive Services (CLAS...gislation . The CLASS provisions are essential for...ties and their caregivers. ,, We urge the Senate ...t affordable to care for families and caregivers. ...
(Date:12/4/2009)...The large, two-day free health clinic sponsored by...n Kansas City on Wednesday and Thursday is not jus...d and has not seen a doctor recently. All particip...primary care. ,, "Many people who attended the th... Houston, New Orleans and Little Rock found out th...
(Date:12/4/2009)...Pamela Bowen, Chief Information Officer at Crescen...Chief Innovation Officer" Appy Award for transform...mputing. Appy Award recipients are nominated based...e Force.com platform in bringing new levels of cus...service, support or IT organizations. ,, "It is a...
(Date:12/4/2009)...ponse to the U.S. Justice Department Drug Enforcem...oxymethyltestosterone, and 19-nor-4,9(10)-androsta...olled Substances Act (CSA), John Gay, executive di... (NPA), the oldest and largest trade association ...y supplements and other natural products, issued t...
(Date:12/4/2009)...dy shows that muscle cells grown in the lab can re...rly. The work, performed in dogs and rats, might u... as gastric reflux and fecal incontinence. , This...hich are the bands of muscle that separate the maj...these areas can cause gastrointestinal esophageal ...
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4[0] Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment[0] Free Health Clinic Event Is Not Just for the Sick[0] Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist[0] Natural Products Association Issues Statement on DEA's Steroid Classification Action[0] Muscle cell infusion shown to strengthen sphincters in animals in Stanford study
... is a statement by Dr. Paul Zeitz, Executive Direc...dent Obama,s global health funding for FY10 as rel... , "We are disappointed by the preliminary global ...Global AIDS Alliance. , , "Our analysis of the...
... Healthcare, a leading provider of specialty healt...artment of Administrative Services to deliver a un...o all state employees. With this award, the State... past two years. , , (Logo: http://www.newsco...
...Corporation of America (Nasdaq: DCAI ) announced...09. , , , , Quarter end patient censu... for the first quarter of 2009 were $23.5 million ...to $1.3 million for the same period last year. ,...
...m proves beneficial in study , , TUESDAY, ...tem helps people with hypertension be more aware o...of their condition and helps them reduce their blo... took 24-hour blood pressure readings. About half ...
...dation-Sponsored Study Focuses on Childcare Provid...5 percent of children ages 3-6 are in child care c... , , A focus group study of child care providers ...rs said they feel pressured by parents to prioriti...
...ic Society elects top officers at 2009 annual meet...ew York, NY (Vocus) May 5, 2009 -- Utah plastic su...e American Society for Aesthetic Plastic Surgery (...osmetic surgery of the face and body. The electio...
Other Medicine News:Health News:Ohio Selects APS Healthcare to Manage Unified Population Health Management Program for State Employees 2Health News:Dialysis Corporation of America Reports First Quarter 2009 Results 2Health News:Dialysis Corporation of America Reports First Quarter 2009 Results 3Health News:Dialysis Corporation of America Reports First Quarter 2009 Results 4Health News:Dialysis Corporation of America Reports First Quarter 2009 Results 5Health News:Dialysis Corporation of America Reports First Quarter 2009 Results 6Health News:Dialysis Corporation of America Reports First Quarter 2009 Results 7Health News:Dialysis Corporation of America Reports First Quarter 2009 Results 8Health News:Phone Monitoring May Help Lower Blood Pressure 2Health News:ABCs and No Skinned Knees: Study Reveals Various Barriers to Physical Activity in Child Care 2Health News:ABCs and No Skinned Knees: Study Reveals Various Barriers to Physical Activity in Child Care 3Health News:Salt Lake City Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery 2Health News:Salt Lake City Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery 3Health News:Salt Lake City Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery 4Statement by Dr. Paul Zeitz, Executive Director, Global AIDS Alliance, Washington, DC on President Obama's Global Health Funding for FY10 as Released by the White House Tuesday, May 5, 2009Ohio Selects APS Healthcare to Manage Unified Population Health Management Program for State EmployeesDialysis Corporation of America Reports First Quarter 2009 ResultsPhone Monitoring May Help Lower Blood PressureABCs and No Skinned Knees: Study Reveals Various Barriers to Physical Activity in Child CareSalt Lake City Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery
(Date:12/4/2009)...hermographic Diagnostic Imaging (TDI), part of a H... continues to provide superior quality infrared im..., dental, TMJ and sinus regions to assist in the e...reas. ,, Thermography utilizes infrared imaging c...e electromagnetic spectrum and produce images. Med...
(Date:12/4/2009)... Deliveries are Transported ,, PHILADELPHIA, Dec... chapter of the American Red Cross are hard at wor...itions that they endure that could potentially put...00 employees went on strike and set up a picket li...ir employer. ,, Red Cross management in Philadelph...
(Date:12/4/2009).... 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) t...onference and webcast. Principal investigators wi...ilzomib in relapsed and/or refractory multiple mye...Hematology (ASH) Annual Meeting. ,, The teleconfer...onday, December 7, 2009. The live webcast will be...
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Baucus Bill Imposes Additional Tax Burdens on Nonprofit Hospitals 57437 1Baucus Bill Imposes Additional Tax Burdens on Nonprofit Hospitals 57437 2Aethlon Medical Inc Announces Annual Meeting Results 14111 1Aethlon Medical Inc Announces Annual Meeting Results 14111 2Aethlon Medical Inc Announces Annual Meeting Results 14111 3Martek Announces Addition to Its Board of Directors 14107 1Martek Announces Addition to Its Board of Directors 14107 2..., 2007 - Enzon,Pharmaceuticals, Inc. (Nasdaq: ENZN...clinical data will be presented at the 2007,Annual...search,(AACR) to be held from April 14 - 18, 2007 ...are as follows: , -- Abstract #1494: EZN-2208, a n... antitumor activity in a panel of human tumor,xeno...
...atitis B e-Antigen,(HBeAg)-Negative Patients Achie...ment, PRINCETON, N.J., April 13, 2007 /PRNewswire-...nnounced data from a cohort of,nucleoside-naive HB.../901, n=99). These data showed that patients who,e...n the blood,after interruption of treatment with B...
Other Medicine Technology:Enzon to Present Preclinical Data From PEG-SN38 and PEGylation,Technology Studies at AACR Meeting 2Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 2Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 3Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 4Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 5| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |